Michitoshi Yabe

Efficacy of pembrolizumab in patients with brain metastasis caused by previously untreated non-small cell lung cancer with high tumor PD-L1 expression

Kazushige Wakuda, Michitoshi Yabe, Hiroaki Kodama et al. · Lung Cancer · 2020 · 36 citations

Medicine, Oncology, Pharmacology +16

Retrospective analysis of osimertinib re-challenge after osimertinib-induced interstitial lung disease in patients with EGFR-mutant non-small cell lung carcinoma

Hiroaki Kodama, Kazushige Wakuda, Michitoshi Yabe et al. · Investigational New Drugs · 2020 · 35 citations

Medicine, Oncology, Pharmacotherapy +14

Impact of weight loss on treatment with PD-1/PD-L1 inhibitors plus chemotherapy in advanced non-small-cell lung cancer

Taichi Miyawaki, Tateaki Naito, Michitoshi Yabe et al. · Supportive Care in Cancer · 2021 · 20 citations

Medicine, Oncology, Pharmacology +16

Prognostic impact of pneumonitis after durvalumab therapy in patients with locally advanced non-small cell lung cancer

Ari Nishimura, Akira Ono, Kazushige Wakuda et al. · Investigational New Drugs · 2021 · 17 citations · Full text

Medicine, Oncology, Radiation Oncology +15

Acute asthma exacerbation due to the SARS-CoV-2 vaccine (Pfizer-BioNTech BNT162b2 messenger RNA COVID-19 vaccine [ComirnatyⓇ])

Masaru Ando, Yoshio Satonaga, Ryuichiro Takaki et al. · International Journal of Infectious Diseases · 2022 · 15 citations · Full text

Medicine, Immunology, Internal Medicine +17